STTK

Shattuck Labs (STTK)

About Shattuck Labs (STTK)

Shattuck Labs, Inc. is a biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Details

Daily high

$3.09

Daily low

$2.82

Price at open

$2.88

52 Week High

$3.38

52 Week Low

$0.69

Market cap

182.9M

Dividend yield

0.00%

Volume

74,990

Avg. volume

365,093

P/E ratio

-2.83

Shattuck Labs News